ATM protein purified from vaccinia virus expression system: DNA binding requirements for kinase activation

Biochemical and Biophysical Research Communications

Volumn 322, Issue 1, 2004, Pages 74-81

  Chun, Helen H ^a   Cary, Robert B ^b   Lansigan, Fredrick ^a   Whitelegge, Julian ^c   Rawlings, David J ^d   Gatti, Richard A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c The Pasarow Mass Spectrom Lab   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Ataxia telangiectasia; ATM; Atomic force microscopy; DNA; Expression; Protein kinase; Purification; Recombinant protein; Vaccinia virus

Indexed keywords

ATM PROTEIN; WORTMANNIN;

ARTICLE; DNA BINDING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; VACCINIA VIRUS;

BINDING SITES; CELL CYCLE PROTEINS; DNA; DNA DAMAGE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HELA CELLS; HUMANS; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; TUMOR SUPPRESSOR PROTEINS; VACCINIA VIRUS;

VACCINIA VIRUS;

EID: 4143061351     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.07.085     Document Type: Article

References (31)

1. R.A. Gatti Ataxia-telangiectasia B. Vogelstein K.W. Kinzler The Genetic Basis of Human Cancer eighth ed. 2002 McGraw-Hill New York 239 266
2. K. Savitsky, S. Sfez, D.A. Tagle, Y. Ziv, A. Sartiel, F.S. Collins, Y. Shiloh, and G. Rotman The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species Hum. Mol. Genet. 4 1995 2025 2032
3. R. Bosotti, and A. Isacchi FAT: a novel domain in PIK-related kinases TIBS 25 2000 225 227
4. Y. Shiloh ATM and related protein kinases: safeguarding genome integrity Nat. Rev. Cancer 3 2003 155 168
5. H.H Chun, X. Sun, S.A. Nahas, S. Teraoka, C.H. Lai, P. Concannon, and R.A. Gatti Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression Mol. Genet. Metab. 80 2003 437 443
6. H. Zhang, P. Chen, K.K. Khanna, S. Scott, M. Gatei, S. Kozlov, D. Watters, K. Spring, T. Yen, and M.F. Lavin Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype Proc. Natl. Acad. Sci. USA 94 1997 8021 8026
7. Y. Ziv, A. Bar-Shira, I. Pecker, P. Russell, T.J. Jorgensen, I. Tsarfati, and Y. Shiloh Recombinant ATM protein complements the cellular A-T phenotype Oncogene 15 1997 159 167
8. S.P. Scott, N. Zhang, K.K. Khanna, A. Khromykh, K. Hobson, D. Watter, and M.F. Lavin Cloning and expression of the ataxia-telangiectasia gene in baculovirus Biochem. Biophys. Res. Commun. 245 1998 144 148
9. G.C.M. Smith, R.B. Cary, N.D. Lakin, B.C. Hann, S.-H. Teo, D.J. Chen, and S.P. Jackson Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM Proc. Natl. Acad. Sci. 96 1999 11134 11139
10. A.A. Goodarzi, and S.P. Lees-Miller Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells DNA Repair 3 2004 753 767
11. D.W. Chan, S.-C. Son, W. Block, R. Ye, K.K. Khanna, M.S. Wold, P. Douglas, A.A. Goodarzi, J. Pelley, Y. Taya, M.F. Lavin, and S.P. Lees-Miller Purification and characterization of ATM from human placenta J. Biol. Chem. 275 2000 7803 7810
12. D.W Chan, C.H. Mody, N.S. Ting, and S.P. Lees-Miller Purification and characterization of the double-stranded DNA-activated protein kinase, DNA-PK, from human placenta Biochem. Cell Biol. 74 1996 67 73
13. N. Rhodes, T.M. Gilmer, and T.J. Lansing Expression and purification of active recombinant ATM protein from transiently transfected mammalian cells Prot. Expr. Purif. 22 2001 462 466
14. M. Mackett, G.L. Smith, and B. Moss Vaccinia virus: a selectable eukaryotic cloning and expression vector Proc. Natl. Acad. Sci. USA 79 1982 7415 7419
15. D. Panicali, and E. Paoletti Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus Proc. Natl. Acad. Sci. USA 79 1982 4927 4931
16. C. Hwang, and M.G. Sanda Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapies Curr. Opin. Mol. Ther. 1 1999 471 479
17. H.L. Kaufman, W. Wang, J. Manola, R.S. DiPaola, Y.J. Ko, C. Sweeney, T.L. Whiteside, J. Schlom, G. Wilding, and L.M. Weiner Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group J. Clin. Oncol. 22 2004 2122 2132
18. E. Ramsburg, N.F. Rose, P.A. Marx, M. Mefford, D.F. Nixon, W.J. Moretto, D. Montefiori, P. Earl, B. Moss, and J.K. Rose Highly effective control of and AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol J. Virol. 78 2004 3930 3940
19. S. Chakrabarti, J.R. Sisler, and B. Moss Compact, synthetic, vaccinia virus early/late promoter for protein expression BioTechniques 23 1997 1094 1097
20. P.L. Earl, B. Moss, L.S. Wyatt, and M.W. Carroll Generation of recombinant vaccinia virus V.B. Chanda Current Protocols in Molecular Biology 3 1998 Wiley New York 16171 161719
21. S.M. Gómez, K.Y. Bil', R. Aguilera, J.N. Nishio, K.F. Faull, and J.P. Whitelegge Transit peptide cleavage sites of integral thylakoid membrane proteins Mol. Cell. Proteomics 2 2003 1068 1085
22. K.D. Brown, Y. Ziv, S.N. Sadanandan, L. Chessa, F.S. Collins, Y. Shiloh, and D.A. Tagle The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage Proc. Natl. Acad. Sci. USA 94 1997 1840 1845
23. D. Watters, K.K. Khanna, H. Beamish, G. Birrell, K. Spring, P. Kedar, M. Gatei, D. Stenzel, K. Hobson, S. Kozlov, N. Zhang, A. Farrell, J. Ramsay, R. Gatti, and M. Lavin Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms Oncogene 14 1997 1911 1921
24. C.E. Canman, D.-S. Lim, K.A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M.B. Kastan, and J.D. Siliciano Activation of the ATM kinase by ionizing radiation and phosphorylation of p53 Science 281 1998 1677 1679
25. S. Banin, L. Moyal, S.-Y. Shieh, Y. Taya, C.W. Anderson, L. Chessa, N.I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv Enhanced phosphorylation of p53 by ATM in response to DNA damage Science 281 1998 1674 1677
26. D.P. Gately, J.C. Hittle, G.K. Chan, and T.J. Yen Characterization of ATM expression, localization, and associated DNA-dependent protein kinase activity Mol. Biol. Chem. 9 1998 2361 2374
27. E. Suzuki, S. Kodama, and M. Watanabe Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation J. Biol. Chem. 274 1999 25571 25575
28. Y. Andegeko, L. Moyal, L. Mittelman, I. Tsarfaty, Y. Shiloh, and G. Rotman Nuclear retention of ATM at sites of DNA double strand breaks J. Biol. Chem. 276 2001 38224 38230
29. S. Kozlov, N. Gueven, K. Keating, J. Ramsay, and M.F. Lavin ATP activates ataxia-telangiectasia mutated (ATM) in vitro. Importance of autophosphorylation J. Biol. Chem. 278 2003 9309 9317
30. C.J. Bakkenist, and M.B. Kastan DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation Nature 421 2003 499 506
31. O. Llorca, A. Rivera-Calzada, J. Grantham, and K.R. Willison Electron microscopy and 3D reconstructions reveal that human ATM kinase uses an arm-like domain to clamp around double-stranded DNA Oncogene 22 2003 3867 3874